A case of urinary retention emerging after fluoxetine (20 mg/day) addition
to low risperidone doses (2 mg/day) is presented. Severe extrapyramidal sid
e-effects (EPS) also occurred after fluoxetine-risperidone combination. Sev
eral possibilities, based on the pharmacodynamic and pharmacokinetic proper
ties of risperidone and fluoxetine, which merit consideration in an attempt
to explain our patient's side-effects, are discussed. Extrapyramidal side-
effects can be due to an increase of the plasma concentration of risperidon
e and/or the intrinsic propensity of fluoxetine to produce EPS. Urinary ret
ention may be the consequence of a central serotoninergic mechanism in, or
without, combination central D-2 blockade.